Year-End Report

LUPUS FOUNDATION OF AMERICA for LUPUS FOUNDATION OF AMERICA

Firm
Client
Income
—
Expenses
$16,994

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Appropriations for DHHS, FDA, CDC, NIH, and DoD FDA Lupus Guidance Document, new therapies for lupus, biomarkers, definitions of lupus flares Federal Working Group on Lupus; National Lupus Patient Registry; Implementation of Medicare Modernization Act; Social Security Disability Regulations; Medicare Part D Regulations; federal budget resolution; Lupus REACH Amendments Act, S. 1359/H.R. 1192

LobbyistCovered position, as disclosed
SARA J CHANG GRASSROOTS COORDINATOR
PRISCILLA CHATMAN —
MAUREEN MITCHELL CONSULTANT
DUANE L PETERS VICE PRESIDENT OF COMMUNICATIONS
MARY WORSTELL —
JULIE ANN YANNES VICE PRESIDENT OF GOVERNMENT RELATIONS

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Social Security Administration (SSA); Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 1192 (110th), S. 1359 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.